| Beyond immune checkpoint blockade: emerging immunological strategies SP Kubli, T Berger, DV Araujo, LL Siu, TW Mak Nature reviews Drug discovery 20 (12), 899-919, 2021 | 244 | 2021 |
| Thymidylate synthase expression in circulating tumor cells: A new tool to predict 5‐fluorouracil resistance in metastatic colorectal cancer patients EA Abdallah, MF Fanelli, MEC Buim, MC Machado Netto, ... International journal of cancer 137 (6), 1397-1405, 2015 | 69 | 2015 |
| MRP1 expression in CTCs confers resistance to irinotecan‐based chemotherapy in metastatic colorectal cancer EA Abdallah, MF Fanelli, V Souza, e Silva, MC Machado Netto, ... International journal of cancer 139 (4), 890-898, 2016 | 57 | 2016 |
| Oncology phase I trial design and conduct: time for a change-MDICT Guidelines 2022 D Araujo, A Greystoke, S Bates, A Bayle, E Calvo, L Castelo-Branco, ... Annals of Oncology 34 (1), 48-60, 2023 | 31 | 2023 |
| Contemporary dose-escalation methods for early phase studies in the immunotherapeutics era DV Araujo, M Oliva, K Li, R Fazelzad, ZA Liu, LL Siu European Journal of Cancer 158, 85-98, 2021 | 29 | 2021 |
| Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study M Oliva, D Chepeha, DV Araujo, JJ Diaz-Mejia, P Olson, A Prawira, ... Journal for Immunotherapy of Cancer 9 (10), 2021 | 26 | 2021 |
| Designing circulating tumor DNA-based interventional clinical trials in oncology DV Araujo, SV Bratman, LL Siu Genome medicine 11, 1-4, 2019 | 24 | 2019 |
| The roles of PTEN, cMET, and p16 in resistance to cetuximab in head and neck squamous cell carcinoma AABA da Costa, FDA Costa, DV Araújo, MPG Camandaroba, ... Medical oncology 36, 1-9, 2019 | 21 | 2019 |
| AVID200, first-in-class TGF-beta 1 and 3 selective and potent inhibitor: Safety and biomarker results of a phase I monotherapy dose-escalation study in patients with advanced … TA Yap, NJ Lakhani, DV Araujo, J Rodon Ahnert, SR Chandana, ... Journal of Clinical Oncology 38 (15_suppl), 3587-3587, 2020 | 20 | 2020 |
| Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics DV Araujo, GA Watson, M Oliva, A Heirali, B Coburn, A Spreafico, LL Siu Cancer Treatment Reviews 92, 102125, 2021 | 18 | 2021 |
| Real world outcomes and hepatotoxicity of infliximab in the treatment of steroid-refractory immune-related adverse events DV Araujo, TP Muniz, A Yang, S Keshavarzi, H Sorotsky, MO Butler, ... Current Oncology 28 (3), 2173-2179, 2021 | 16 | 2021 |
| First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial) A Spreafico, AA Heirali, DV Araujo, TJ Tan, M Oliva, PHH Schneeberger, ... Annals of Oncology 34 (6), 520-530, 2023 | 15 | 2023 |
| Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC)–an International mRCC Database Consortium (IMDC … DV Araujo, JC Wells, AR Hansen, N Dizman, SK Pal, B Beuselinck, ... Journal of Geriatric Oncology 12 (5), 820-826, 2021 | 15 | 2021 |
| Characteristics of immune checkpoint inhibitors trials associated with inclusion of patients with HIV: a systematic review and meta-analysis H Sorotsky, D Hogg, E Amir, DV Araujo JAMA Network Open 2 (11), e1914816-e1914816, 2019 | 12 | 2019 |
| Applications of circulating tumor DNA in a cohort of phase I solid tumor patients treated with immunotherapy DV Araujo, A Wang, D Torti, A Leon, K Marsh, A McCarthy, H Berman, ... JNCI Cancer Spectrum 5 (3), pkaa122, 2021 | 11 | 2021 |
| The day after COVID-19—Time to rethink oncology clinical research DV Araujo, GA Watson, LL Siu JAMA oncology 7 (1), 23-24, 2021 | 11 | 2021 |
| Complete metastasectomy in renal cell carcinoma: a propensity-score matched by the International Metastatic RCC Database Consortium prognostic model AF Fares, DV Araujo, V Calsavara, AO Saito, MN Formiga, AA Dettino, ... ecancermedicalscience 13, 2019 | 9 | 2019 |
| Impact of pharmacodynamic biomarkers in immuno-oncology phase 1 clinical trials A Salawu, A Hernando-Calvo, RY Chen, DV Araujo, M Oliva, ZA Liu, ... European Journal of Cancer 173, 167-177, 2022 | 8 | 2022 |
| SNOW: Sitravatinib and nivolumab in oral cavity cancer (OCC) window of opportunity study. M Oliva Bernal, DV Araujo, DB Chepeha, A Prawira, A Spreafico, ... Journal of Clinical Oncology 38 (15_suppl), 6569-6569, 2020 | 8 | 2020 |
| P856 AVID200, first-in-class TGF-beta1 and beta3 selective inhibitor: Results of a phase 1 monotherapy dose escalation study in solid tumors and evidence of target engagement … T Yap, D Araujo, D Wood, JF Denis, T Gruosso, G Tremblay, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 1), 2020 | 8 | 2020 |
Lillian SiuPrincess Margaret Cancer CentreVerified email at uhn.ca
